|
Applied Therapeutics Inc (APLT) |
|
Applied Therapeutics Inc
APLT's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Applied Therapeutics Inc growth rates, revenue grew
in II. Quarter 2024 from the same quarter a year ago.
Ranking at No. 3038
Major Pharmaceutical Preparations industry recorded
growth of revenues by 5.15 %
Applied Therapeutics Inc realized net income compared to net loss a year ago in II. Quarter 2024
• More on APLT's Growth
|
|
Applied Therapeutics Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 16.3 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.48.
• More on APLT's Valuation
|
|
|
|
|
Applied Therapeutics Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 16.3 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.48.
Applied Therapeutics Inc Price to Book Ratio is at 19.49 lower than Industry Avg. of 83. and higher than S&P 500 Avg. of 0
• More on APLT's Valuation
|
|
Applied Therapeutics Inc net profit margin of 2012.5 % is currently ranking no. 5 in Major Pharmaceutical Preparations industry, ranking no. 7 in Healthcare sector and number 19 in S&P 500.
• More on APLT's Key Ratios
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com